Farrell Michael J.'s Form 4 filing
Resmed Inc (RMD) · filed Nov 12, 2024
- Accession no.
- 0001127602-24-027086
- Filed
- Nov 12, 2024
- Trade date
- Nov 7-11, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.62M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Farrell Michael J.CIK 0001485164 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2024 | ResMed Common Stock | MOption exerciseAcquired | +14,683 | $84.98 | +$1,247,761.34 | 478,937 | Direct | |
| Nov 7, 2024 | ResMed Common Stock | SSaleDisposed | −14,683 | $246.26F4 | −$3,615,835.58 | 464,254 | Direct | |
| Nov 11, 2024 | ResMed Common Stock | FTax withholdingDisposed | −3,101.38 | $252.38 | −$782,726.28 | 461,152 | Direct | |
| Nov 11, 2024 | ResMed Common Stock | FTax withholdingDisposed | −2,226.86 | $252.38 | −$562,014.93 | 458,925 | Direct | |
| Nov 11, 2024 | ResMed Common Stock | FTax withholdingDisposed | −3,452.9 | $252.38 | −$871,442.9 | 455,472 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2024 | ResMed Common Stock | MOption exerciseDisposed | −14,683 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
This transaction was executed in multiple trades at prices ranging from $244.74 - $248.38 The price reported above reflects the weighted average sale price.
Referenced by the price of 1 transaction in Table I.